In this region, global Sleep Apnea Market is projected to reach USD 14,119.5 million by 2024 from USD 7,800.0 million in 2016, at a CAGR of 7.7% in the forecast period 2017 to 2024.
The global sleep apnea device market is segmented on the basis of product type, end user and geography.
On the basis of type, sleep apnea device market is categorized into: diagnostic devices and therapeutic devices.
On the basis of product type, the diagnostic sleep apnea device market is segmented into polysomnography devices, respiratory polygraphs, pulse oximeters and actigraph systems.
On the basis of product type, the therapeutic sleep apnea devices are segmented into positive airway pressure devices (PAP), continuous positive airway pressure devices (CPAP), automatically adjusting positive airway pressure devices (APAP), masks, adaptive servo ventilation, airway clearance system, oxygen concentrators, oral appliances and accessories.
On the basis of end users, the global sleep apnea devices market is further segmented into hospitals, sleep clinics, community healthcare and home healthcare. In 2017, the hospitals segment dominates the global sleep apnea device market.
Market Dynamics
Drivers
Technological Advancement
Increasing Prevalence of Sleep Apnea
Rising Geriatric Population
Changing Lifestyle
Restraints
Side Effect of Sleep Apnea Devices
Regulatory Scenario
Opportunities
Emerging Market
Undiagnosed Patient Pool
Challenges
Death Due to Sleep Apnea Devices
Alternative Treatment Option
High Competition
Koninklijke Philips N.V. dominated the sleep apnea devices market in 2016, followed by Natus Medical Incorporated, and Nihon Kohden.
Key Topics Covered:
1. Introduction
2. Market Segmentation
3. Research Methodology
4. Market Overview
5. Executive Summary
6. Premium Insights
7. Global Sleep Apnea Device Market, by Product Type
8. Global Sleep Apnea Device Market, by End User
9. Global Sleep Apnea Devices Market, by Geography
10. Global Sleep Apnea Devices Market, Company Share
West Physics Consulting, LLC ("West Physics"), the leading national provider of integrated medical and health physics services, announced today that it has completed the purchase of the medical physics service division of Tricord, Inc. ("Tricord"), a...
Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced today the successful closing of its oversubscribed $15 million Series A funding round. The round was led by Quiet Capital and included...
Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its...
Burrell College of Osteopathic Medicine (BCOM) attained the highest level of accreditation from the American Osteopathic Association (AOA) Commission on Osteopathic College Accreditation (COCA). Burrell has been awarded the prestigious accreditation...
Radiance Biopharma ("Radiance" or the "Company"), a biopharmaceutical company specializing in the development of novel Antibody Drug Conjugates (ADCs) and Bispecific ADCs (BsADCs) treatments for cancers, today announced that...
Election of the board of directors and auditor
The annual general meeting in Orexo AB (publ) on 26 April 2024 resolved, in accordance with the nomination committee's proposal, that the number of board members shall be five with no deputy board...